About Lisa Foster

Articles by Lisa Foster

Acute Promyelocytic Leukemia: A Subtype of AML
Nov 15, 2023
Managing Iron Overload In MDS
Nov 09, 2023
A New Treatment Option Being Investigated For High Risk MDS And AML Patients
Nov 08, 2023
A New Treatment Option Being Investigated For High Risk MDS And AML Patients
Nov 08, 2023
Promising Results For Treating DLBCL With Odronextamab
Oct 26, 2023
Chemotherapy Treatment And The Use Of Rituximab In DLBCL
Oct 25, 2023
New Treatment For Chronic Kidney Disease And Type 1 Diabetes
Oct 24, 2023
$Ivosidenib Approved For Treating Relapse Or Refractory MDS With An IDH1 Mutation image$

Ivosidenib Approved For Treating Relapse Or Refractory MDS With An IDH1 Mutation
Oct 24, 2023
Polivy Is A New Line Of Treatment For DLBCL
Oct 22, 2023
The Effectiveness Of Voruciclib As A Monotherapy And In Combination With Venetoclax
Oct 17, 2023
Uproleselan Targets E-Selectin Biomarkers in AML
Oct 10, 2023
$The FDA Approves Columvi For Relapsed/Refractory DLBCL image$

The FDA Approves Columvi For Relapsed/Refractory DLBCL
Oct 08, 2023
The Promising Treatment Of Imetelstat And Transfusion Independence
Oct 05, 2023
The Use Of Antithymocyte Globulin Immunotherapy When Treating Low-Risk MDS
Oct 03, 2023
Phase 3 Results Of Iomab-B Show Success For Transplanted AML
Oct 03, 2023
Hyperkalemia (High Potassium) And Kidney Disease
Sep 12, 2023
The TMIGD1 Gene And Its Contribution To Chronic Kidney Disease
Sep 06, 2023
Aortic Stenosis, Kidney Disease And Aortic Valve Replacement
Sep 05, 2023
What is MRD Testing in AML?
Aug 31, 2023
Nexavar (Sorafenib) Shows Relapse-Free Success When Used After Transplant
Aug 29, 2023
IgA Nephropathy (Berger Disease) As A Kidney Disease
Aug 29, 2023
An Effective Treatment For Kidney Disease Due To aHUS
Aug 22, 2023
Diagnosing And Treating Secondary AML
Aug 17, 2023
Connection Between Hepatitis And Kidney Disease
Aug 17, 2023